News

In a remarkable leap forward for vision science, the Limnopharma team has recently unveiled groundbreaking research in the fight against retinitis pigmentosa, a leading cause of inherited blindness. This achievement not only shines a light on new therapeutic avenues...

Limnopharma, specialized in the development of new therapies for various retinal diseases, has been named one of the 100 best startups of 2023 by the Spanish Association of Science and Technology Parks (APTE). The company focuses on the development of new treatments...

As a result of the collaboration with Inoviem company, the direct interaction between lim21 and one target protein has been established. The identification of this target protein is in line with previous findings and corroborates a pathway involving activation of...

Dr. Francisco Javier Díaz Corrales, co-founder of Limnopharma and renowned scientist at the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), has been awarded a prestigious award for his leadership and dedication in gene therapy research for...

In 2022, Limnopharma engaged in numerous investment events and biotechnology expos. The initial half of the year saw us participating virtually, but from May onwards, we transitioned to in-person attendance. Our involvement included the virtual Bioeurope Spring,...

Limnopharma’s team in collaboration with Prof. Alberto Zafra from the University of Granada has just carried out biodistribution experiments of LIM21 administered in eye drops in pigs. The animals were handled by expert veterinarians at IAVANTE, located in the Health...

Limnopharma signs an agreement with Inoviem Scientific and Hybrigenics (now Aton) to investigate the mode of action of lim21. The agreement covers a 2 step process to establish how lim21 exerts its therapeutic effect. First, the target protein(s) interacting with...

Covirán has formalized this week its direct participation in Limnopharma through a convertible note. From Limnopharma we thank the Covirán Group for its trust and support for our project, which represents a boost and allows us to continue working with the aim of...

Limnopharma has participated in the health section at Alhambra Venture 2022, being awarded as the best startup in the Health & Bio sector. Alhambra Venture is the most important event that connects entrepreneurs and investors in southern Spain. Since 2014,...